Arvee Laboratories (India) Ltd.
NSE:ARVEE.NS
165.24 (INR) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||
Net Income
| 10.518 | 61.652 | 34.49 | 36.414 | 30.906 | 25.441 | 19.159 | 8.603 | 5.355 | -10.063 | 0.232 | 0.531 |
Depreciation & Amortization
| 14.995 | 20.812 | 23.819 | 24.681 | 23.505 | 24.121 | 21.561 | 20.688 | 14.853 | 7.256 | 2.243 | 0.069 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 28.858 | -36.435 | -7.837 | -33.703 | 52.724 | 37.573 | -6.891 | -25.192 | 12.333 | 64.971 | -21.483 | 36.677 |
Accounts Receivables
| 61.485 | -1.349 | -42.449 | -13.664 | 14.003 | 75.684 | -72.681 | -21.427 | -44.903 | 13.904 | -16.195 | -13.535 |
Inventory
| -18.269 | 11.589 | 17.04 | -9.635 | -18.584 | 35.493 | -19.349 | 8.428 | -6.965 | -34.32 | -23.588 | -5.794 |
Accounts Payables
| -12.921 | -22.842 | 8.826 | -2.684 | 32.765 | -57.443 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| -1.437 | -23.834 | 8.745 | -7.72 | 24.541 | -16.161 | 12.458 | -33.62 | 19.298 | 99.291 | 2.105 | 42.471 |
Other Non Cash Items
| 12.708 | -16.74 | -10.313 | -10.287 | -3.8 | 7.421 | 26.334 | 28.069 | 29.723 | 23.774 | 15.961 | 1.275 |
Operating Cash Flow
| 67.079 | 29.289 | 40.159 | 17.106 | 103.336 | 94.555 | 60.162 | 32.168 | 62.264 | 85.938 | -3.047 | 38.552 |
Investing Activities: | ||||||||||||
Investments In Property Plant And Equipment
| -25.859 | -14.84 | -23.641 | -22.906 | -22.853 | -15.028 | -13.392 | -15.25 | -46.177 | -56.666 | -62.837 | -33.424 |
Acquisitions Net
| 0 | 0.17 | 0 | 0.491 | 9.388 | 2.5 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| -29.825 | -0.17 | 0 | -0.491 | -11.447 | -19.495 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0.083 | 21.581 | 13.55 | 2.059 | 1.039 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 4.23 | 2.181 | 2.653 | 3.314 | -7.99 | 2.5 | 1.082 | 5.423 | 1.014 | 0.765 | 0 | 0.939 |
Investing Cash Flow
| -51.454 | -12.576 | 0.593 | -6.042 | -30.843 | -28.483 | -12.311 | -9.827 | -45.163 | -55.901 | -62.837 | -32.485 |
Financing Activities: | ||||||||||||
Debt Repayment
| 0 | -21.314 | -57.478 | 50.125 | -90.061 | -44.11 | -91.193 | 1.419 | 7.636 | 1.85 | 52.995 | -3.684 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 14.6 | 0 | 10.5 | 0 | 29.5 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| -2.499 | -2.856 | 0 | -4.921 | -8.907 | -5.137 | 38.765 | -30.628 | -30.731 | -24.54 | 13.494 | -2.315 |
Financing Cash Flow
| -2.499 | -24.17 | -60.513 | 45.204 | -99.187 | -49.248 | -37.828 | -25.255 | -12.595 | -22.69 | 66.489 | -5.999 |
Other Information: | ||||||||||||
Effect Of Forex Changes On Cash
| 0 | -0 | -33.461 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| 66.484 | -7.456 | -19.76 | 56.268 | -26.695 | 16.824 | 10.023 | -2.913 | 4.507 | 7.347 | 0.606 | 0.068 |
Cash At End Of Period
| 75.401 | 5.375 | 46.292 | 66.053 | 9.785 | 36.48 | 19.655 | 9.632 | 12.546 | 8.04 | 0.693 | 0.087 |